Hepatitis C Virus (HCV) Treatment Completion or Withdrawal

This study has been completed.

First Received: May 6, 2008 Last Updated: October 30, 2008 History of Changes

Sponsored by:	Department of Veterans Affairs
Information provided by:	Department of Veterans Affairs
ClinicalTrials.gov Identifier:	NCT00674492

Purpose

Qualitative pilot study of patients' views of their experience with antiviral treatment for hepatitis C.

Condition
Hepatitis C

MedlinePlus related topics: Hepatitis Hepatitis C

U.S. FDA Resources

Study Type:	Observational
Study Design:	Retrospective
Official Title:	Patients' View of Hepatitis C Treatment Completion or Withdrawal

Further study details as provided by Department of Veterans Affairs:

Primary Outcome Measures:

Attributes of treatment experience identified in inductive qualitative analysis [ Time Frame: Zero to five years since ending treatment. ] [ Designated as safety issue: No ]

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	18
Study Start Date:	May 2008
Study Completion Date:	August 2008
Primary Completion Date:	August 2008 (Final data collection date for primary outcome measure)

Groups/Cohorts
1 patients who initiated antiviral treatment for hepatitis C

Detailed Description:

Qualitative pilot study of patient' views of their experiences with antiviral treatment for hepatitis C. Two groups of patients will be sampled: nine who completed a 24 or 48 week course of treatment and nine who withdrew from treatment prior to planned end. Interview data will be analyzed using narrative and grounded theory methods to identify attributes of treatment experience that may discriminate between completion and withdrawal.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

VHA patients who ever initiated antiviral treatment for hepatitis C.

Criteria

Inclusion Criteria:

Ever initiated anitiviral treatment for hepatitis C.

Exclusion Criteria:

none

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00674492

Locations

United States, Massachusetts
VA New England Health Care System
Bedford, Massachusetts, United States, 01730

Sponsors and Collaborators

Department of Veterans Affairs

Investigators

Principal Investigator:

Jack A Clark, PhD

VA New England Health Care System

More Information

No publications provided

Responsible Party:	Department of Veterans Affairs ( Clark, Jack - Principal Investigator )
Study ID Numbers:	SHP 08-193
Study First Received:	May 6, 2008
Last Updated:	October 30, 2008
ClinicalTrials.gov Identifier:	NCT00674492 History of Changes
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Virus Diseases
Hepatitis
Liver Diseases

Digestive System Diseases
Hepatitis, Viral, Human
Hepatitis C

Additional relevant MeSH terms:

Virus Diseases
Hepatitis
RNA Virus Infections
Liver Diseases

Digestive System Diseases
Flaviviridae Infections
Hepatitis, Viral, Human
Hepatitis C

ClinicalTrials.gov processed this record on May 07, 2009